Commentary: "Treatment of hypertension and prevention of dementia" by Olivier Hanon and Françoise Forette

Alzheimer's and Dementia

Volumn 1, Issue 1, 2005, Pages 38-40

  Kuller, Lewis H ^a   Lopez, Oscar L ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

ALCOHOL WITHDRAWAL; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; DEMENTIA; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RISK REDUCTION; TREATMENT OUTCOME;

EID: 33644795138     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2005.06.023     Document Type: Note

References (19)

1. F. Forette M.L. Seux J.A. Staessen L. Thijs M.R. Babarskiene S. Babeanu et. al. Systolic Hypertension in Europe Investigators The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study Arch Intern Med 162 2002 2046-2052
2. P.B. Gorlick Prevention J.V. Bowler V. Hachinski Vascular cognitive impairment, preventable dementia 2003 Oxford University Press New York 308-320
3. D.A. Snowden L.H. Greiner J.A. Mortimer K.P. Riley P.A. Greiner W.R. Markesbery Brain infarction and clinical expression of Alzheimer's disease. The Nun Study JAMA 277 1997 813-817
4. C. Iadecola P.B. Gorelick Converging pathogenic mechanisms in vascular and neurodegenerative dementia Stroke 34 2003 335-337
5. L.H. Kuller O.L. Lopez A. Newman N.J. Beauchamp G. Burke C. Dulberg et. al. Risk factors for dementia in the Cardiovascular Health Cognition Study Neuroepidemiology 22 2003 13-22
6. O.L. Lopez L.H. Kuller J.T. Becker W.J. Jagust S.T. DeKosky A. Fitzpatrick et. al. Classification of vascular dementia in the Cardiovascular Health Cognition Study Neurology 64 2005 1539-1547
7. L.H. Kuller O.L. Lopez W.J. Jagust J.T. Becker S.T. DeKosky C. Lyketsos et. al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study Neurology 64 2005 1548-1552
8. M.M. Breteler J.C. van Swieten M.L. Bots et. al. Cerebral white mater lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study Neurology 44 1994 1246-1252
9. L. White H. Petrovich J. Hardman J. Nelson et. al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants J.C. de la Torre R. Kalaria K. Nakajima K. Nagata Alzheimer's disease. Vascular etiology and pathology. Ann NY Acad Sci 977 2002 9-23
10. S.M. Greenberg E. Gurol J. Rosand E.E. Smith Amyloid angiopathy-related vascular cognitive impairment Stroke 35 2004 2616-2619
11. E. Kovari G. Gold F.R. Herrman et. al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging Stroke 35 2004 410-414
12. A.E. Roher C. Esch T.A. Kokjohn et. al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease Arterioscler Thromb Vasc Biol 23 2003 2055-2062
13. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255-3264
14. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981-2997
15. H.M. Fillit R.N. Butler A.W. O'Connell M.S. Albert J.E. Birren C.W. Cotman et. al. Achieving and maintaining cognitive vitality with aging Mayo Clin Proc 77 2002 681-69
16. L.J. Podewils E. Guallar L.H. Kuller L.P. Fried O.L. Lopez M. Carlson et. al. Physical activity, APOE genotype, and dementia risk: Findings form the Cardiovascular Health Cognition Study Am J Epidemiol 161 2005 639-651
17. K.J. Mukamal L.H. Kuller A.L. Fitzpatrick W.T. Longstreth Jr M.A. Mittleman D.S. Siscovick Prospective study of alcohol consumption and risk of dementia in older adults JAMA 289 2003 1405-1413
18. P.B. Gorelick W.M. Feinberg Cognitive Vitality and the Role of Stroke and Cardiovascular Disease Risk Factors. Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago Stroke 36 2005 875-879
19. S.A. Shumaker C. Legault S.R. Rapp L. Thal R.B. Wallace J.K. Ockene et. al. WHIMS Investigators Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: A randomized controlled trial JAMA 289 2003 2651-2662